Scynexis Inc

SCYXNASDAQ · USD
4.66USD0.00 (+0.87%)
537

Scynexis Inc (SCYX) Options Open Interest

SCYX options open interest is — contracts. The 2-week average daily volume is 45 contracts across the chain.

Read more

Monitoring SCYX open interest helps you see where real money is positioned on Scynexis Inc's options and which strikes are attracting the most commitment from traders. Scynexis Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor SCYX options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising SCYX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Scynexis Inc to settle.

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp.

The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where SCYX open interest is concentrated. Our scanner maps Scynexis Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Scynexis Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
5.000.504.602.55727%+0.7679160
7.50—0.150.15193%+0.1733129
2.500.104.902.50380%+0.88004
10.000.050.150.10238%+0.10700
Puts
2.50—0.050.05204%-0.049590
5.000.102.001.05215%-0.468214
7.500.505.503.00202%-0.81060
10.003.007.905.45253%-0.87300

As of September 29, 2026

Follow the money

Track SCYX open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial